Atreca Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

John Orwin

Chief executive officer

US$927.0k

Total compensation

CEO salary percentage64.8%
CEO tenure6yrs
CEO ownership0.2%
Management average tenure4.8yrs
Board average tenure7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has John Orwin's remuneration changed compared to Atreca's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$98m

Jun 30 2023n/an/a

-US$85m

Mar 31 2023n/an/a

-US$93m

Dec 31 2022US$927kUS$601k

-US$97m

Sep 30 2022n/an/a

-US$105m

Jun 30 2022n/an/a

-US$110m

Mar 31 2022n/an/a

-US$108m

Dec 31 2021US$4mUS$583k

-US$109m

Sep 30 2021n/an/a

-US$103m

Jun 30 2021n/an/a

-US$98m

Mar 31 2021n/an/a

-US$92m

Dec 31 2020US$5mUS$567k

-US$86m

Sep 30 2020n/an/a

-US$83m

Jun 30 2020n/an/a

-US$76m

Mar 31 2020n/an/a

-US$74m

Dec 31 2019US$845kUS$507k

-US$67m

Sep 30 2019n/an/a

-US$59m

Jun 30 2019n/an/a

-US$53m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$5mUS$319k

-US$38m

Compensation vs Market: John's total compensation ($USD927.03K) is above average for companies of similar size in the German market ($USD398.66K).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


CEO

John Orwin (58 yo)

6yrs

Tenure

US$927,033

Compensation

Mr. John A. Orwin, M.B.A. serves as Chairman of the Board for Nested Therapeutics since February 2024. He serves as Chairman of the Board of AnaptysBio, Inc. since September 15, 2023. He has been President...


Leadership Team

NamePositionTenureCompensationOwnership
John Orwin
President6yrsUS$927.03k0.20%
$ 5.5k
Tito Serafini
Founder & Directorno dataUS$665.50k0.74%
$ 20.9k
Rick Ruiz
Principal Accounting Officerless than a yearno datano data
Courtney Phillips
General Counsel & Corporate Secretary4.8yrsno data0.073%
$ 2.1k
Roger Ruiz
Vice President of Financeno datano data0.067%
$ 1.9k

4.8yrs

Average Tenure

58.5yo

Average Age

Experienced Management: 0C1's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
John Orwin
President6yrsUS$927.03k0.20%
$ 5.5k
Tito Serafini
Founder & Director14.3yrsUS$665.50k0.74%
$ 20.9k
Brian Atwood
Independent Chairman of the Board10.3yrsUS$97.77k0.13%
$ 3.5k
Lawrence Steinman
Chairman of External Scientific Advisory Board & Technical Advisor4.7yrsUS$150.00kno data
Franklin Berger
Independent Director9.5yrsUS$71.77k0.25%
$ 7.0k
Kristine Ball
Independent Director3.9yrsUS$64.27k0%
$ 0
William Robinson
Director13.3yrsUS$312.77k0.93%
$ 26.3k
David Lacey
Independent Director7.9yrsUS$70.77k0%
$ 0
Douglas Crawford
Board Observerno datano datano data
Andrew Farnum
Board Observerno datano datano data
Lindsey Rolfe
Independent Director4.7yrsUS$62.77k0%
$ 0
Stacey Ma
Independent Director2.8yrsUS$57.77k0%
$ 0

7.0yrs

Average Tenure

59yo

Average Age

Experienced Board: 0C1's board of directors are considered experienced (7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.